PAPER Ahmed GA, Khalil SK, Hotaby WE, Abbas L, Farrag AR, Aal WE, Sherif HH, Abdel-Rahman EA, Saber SH, Hassan M, Hassan MH, Balgoon M, Qusti S, Kotb M, Ali SS
SEARCH RESULTS
250 RESULTS
PAPER Kim K, Lee CH, Park CB
Chemical sensing platforms for detecting trace-level Alzheimer's core biomarkers.
Chem Soc Rev. 2020 Aug 7;49(15):5446-5472. Epub 2020 Jul 6 PubMed: 32627779PAPER Topart C, Werner E, Arimondo PB
Wandering along the epigenetic timeline.
Clin Epigenetics. 2020 Jul 2;12(1):97. PubMed: 32616071PAPER Noah AM, Almghairbi D, Moppett IK
Optical coherence tomography in mild cognitive impairment- Systematic review and meta-analysis.
Clin Neurol Neurosurg. 2020 Sep;196:106036. Epub 2020 Jun 22 PubMed: 32623211PAPER Farkhondeh T, Khan H, Aschner M, Samini F, Pourbagher-Shahri AM, Aramjoo H, Roshanravan B, Hoyte C, Mehrpour O, Samarghandian S
Impact of Cannabis-Based Medicine on Alzheimer's Disease by Focusing on the Amyloid β-Modifications: A Systematic Study.
CNS Neurol Disord Drug Targets. 2020;19(5):334-343. PubMed: 32640965PAPER Nakanishi H, Nonaka S, Wu Z
Microglial Cathepsin B and Porphyromonas gingivalis Gingipains as Potential Therapeutic Targets for Sporadic Alzheimer's Disease.
CNS Neurol Disord Drug Targets. 2020;19(7):495-502. PubMed: 32640970PAPER Kumar R, Gulati M, Singh SK, Sharma D, Porwal O
Road From Nose to Brain for Treatment of Alzheimer: The Bumps and Humps.
CNS Neurol Disord Drug Targets. 2020 Jul 8; PubMed: 32640969PAPER Hammond TC, Xing X, Wang C, Ma D, Nho K, Crane PK, Elahi F, Ziegler DA, Liang G, Cheng Q, Yanckello LM, Jacobs N, Lin AL
β-amyloid and tau drive early Alzheimer's disease decline while glucose hypometabolism drives late decline.
Commun Biol. 2020 Jul 6;3(1):352. PubMed: 32632135PAPER Song L, Zhu C, Zheng W, Lu D, Jiao H, Zhao R, Bao Z
Computational systematic selectivity of the Fasalog inhibitors between ROCK-I and ROCK-II kinase isoforms in Alzheimer's disease.
Comput Biol Chem. 2020 Jun 22;87:107314. PubMed: 32619776PAPER Ptomey LT, Szabo-Reed AN, Martin LE, Mayo MS, Washburn RA, Gorczyca AM, Lepping RJ, Lee P, Forsha DE, Sherman JR, Danon JC, Donnelly JE
The promotion of physical activity for the prevention of Alzheimer's disease in adults with Down Syndrome: Rationale and design for a 12 Month randomized trial.
Contemp Clin Trials Commun. 2020 Sep;19:100607. Epub 2020 Jun 30 PubMed: 32642594PAPER Clarke N, Foltz P, Garrard P
How to do things with (thousands of) words: Computational approaches to discourse analysis in Alzheimer's disease.
Cortex. 2020 Aug;129:446-463. Epub 2020 May 19 PubMed: 32622173PAPER Wei H
New Approaches to Develop Drug Treatment for Alzheimer's Disease: Targeting Calcium Dysregulation.
Curr Alzheimer Res. 2020;17(4):311-312. PubMed: 32623998PAPER Alam J, Jaiswal V, Sharma L
Screening of Antibiotics against β-amyloid as Anti-amyloidogenic Agents: A Drug Repurposing Approach.
Curr Comput Aided Drug Des. 2020 Jul 3; PubMed: 32619176PAPER Meyer A, Handabaka I, Ehrensperger MM, Gschwandtner U, Hatz F, Monsch AU, Stieglitz RD, Fuhr P
A Comparison of Serial Position Effects in Patients with Mild Cognitive Impairment due to Parkinson's Disease or to Alzheimer's Disease.
Dement Geriatr Cogn Disord. 2020;49(2):170-178. Epub 2020 Jul 7 PubMed: 32634809PAPER Baranauskas M, Jurkonis R, Lukoševičius A, Makūnaitė M, Matijošaitis V, Gleiznienė R, Rastenytė D